MedPath

CYPROHEPTADINE HYDROCHLORIDE

Cyproheptadine Hydrochloride Tablets, USP

Approved
Approval ID

d7d778a4-f016-4e42-85b3-b3fc0c578106

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 15, 2021

Manufacturers
FDA

Quality Care Products, LLC

DUNS: 831276758

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CYPROHEPTADINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55700-700
Application NumberANDA208938
Product Classification
M
Marketing Category
C73584
G
Generic Name
CYPROHEPTADINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateNovember 20, 2018
FDA Product Classification

INGREDIENTS (5)

CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CYPROHEPTADINE HYDROCHLORIDEActive
Quantity: 4 mg in 1 1
Code: NJ82J0F8QC
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CYPROHEPTADINE HYDROCHLORIDE - FDA Drug Approval Details